NorthWest Biotherapeutics Inc (NWBO)

[dennisdave]

I agree with you. What happened is that management has themselves painted in a corner by chaining the journal publication to the disclosure of topline data. Now that the journal has encountered substantial delays the paint just won't dry so they cant step out of that locked room anymore. Had they followed the route that normal functioning biotechs do: disclosing topline data with the promise of a journal publication in the future then BLA submission/request RA approval then the news of approval (or not) we would not be in this sh*t forsaking awful mess.

I have no idea why the publication has been delayed and what the obstacles delaying the publication are but in my view, it's material information at this point, and they should disclose the reasons for the delay.